---
figid: PMC6395653__41598_2019_39109_Fig3_HTML
figtitle: The metabolic network
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6395653
filename: 41598_2019_39109_Fig3_HTML.jpg
figlink: /pmc/articles/PMC6395653/figure/Fig3/
number: F3
caption: 'The metabolic network. The core metabolism of cancer cells integrates glycolysis,
  the pentose phosphate pathway, the citric acid cycle, lipogenesis and amino acids
  metabolism. Biomass synthesis is described as the incorporation of amino acids,
  intermediate metabolites and palmitic acid. The metabolic therapy includes Diclofenac
  as hexokinase and lactate dehydrogenase inhibitor; alpha-Lipoic acid (ALA) as pyruvate
  dehydrogenase activator; Hydroxycitrate (HCA) as ATP citrate lyase inhibitor; Metformin
  as ATP synthase inhibitor and NAD leakage activator. Notations: ACCOA: Acetyl-CoenzymeA,
  ACCOA: Acetyl-CoenzymeA, ACL: ATP-citrate lyase, ADP: Adenosine diphosphate, AK:
  Adenylate kinase, AKG: α-ketoglutarate, ALA: Extracellular alanine, AMP: Adenosine
  monophosphate, ARG: Extracellular arginine, ASN: Asparaginase, ASP: Extracellular
  aspartate, ATP: Adenosine triphosphate, CIT: Citrate, CO2: Carbone dioxide, DICLO:
  Extracellular diclofenac, EGLC: Extracellular glucose, EGLN: Extracellular glutamine,
  EGLU: Extracellular glutamate, F6P: Fructose-6- Phosphate, FADH2: Flavine adenine
  dinucleotide, FUM: fumarate, G6P: Glucose-6-phosphate, GAP: Glyceraldehyde 3-phosphate,
  concentration, GlnT: Glutamine synthetase, GLU: Glutamate, GLY: Extracellular Glycine,
  H2O: Hydrogen dioxide, HCIT: Extracellular hydroxicitrate, HIS: Extracellular histidine,
  HISARGTA: Histidine/arginine transamination, ILE: Extracellular isoleucine, LA:
  Extracellular lipoic acid, LAC: Extracellular lactate, LEU: Extracellular leucine,
  LYS: Extracellular lysine, MAL: Malate, ME: Malic enzyme, Metformin: Extracellular
  metformin, NAD: Nicotinamide adenine dinucleotide (Oxidized), NADH: Nicotinamide
  adenine dinucleotide (reduced), NADP: nictoniamide adenine dinucleottide phosphate,
  NADPH: nictoniamide adenine dinucleotide phosphate (reduced), NH4: Extracellular
  ammonia, OXA: Oxaloacetate, PALM: Palmitate, PEP: Phosphoenolpyruvate, Pi: inorganic
  phosphate, PK: Pyruvate kinase, PPRibP: Nucleotide synthesis, PYR: Pyruvate, R5P:
  Ribulose-5-phosphate, SER: Extracellular serine, SUC: succinate, SUCCOA: Succinyl
  coenzyme A, THR: Extracellular threonine, TYR: Extracellular tyrosine, VAL: Extracellular
  valine.'
papertitle: Metabolic therapies inhibit tumor growth in vivo and in silico.
reftext: Jorgelindo da Veiga Moreira, et al. Sci Rep. 2019;9:3153.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9425414
figid_alias: PMC6395653__F3
figtype: Figure
redirect_from: /figures/PMC6395653__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6395653__41598_2019_39109_Fig3_HTML.html
  '@type': Dataset
  description: 'The metabolic network. The core metabolism of cancer cells integrates
    glycolysis, the pentose phosphate pathway, the citric acid cycle, lipogenesis
    and amino acids metabolism. Biomass synthesis is described as the incorporation
    of amino acids, intermediate metabolites and palmitic acid. The metabolic therapy
    includes Diclofenac as hexokinase and lactate dehydrogenase inhibitor; alpha-Lipoic
    acid (ALA) as pyruvate dehydrogenase activator; Hydroxycitrate (HCA) as ATP citrate
    lyase inhibitor; Metformin as ATP synthase inhibitor and NAD leakage activator.
    Notations: ACCOA: Acetyl-CoenzymeA, ACCOA: Acetyl-CoenzymeA, ACL: ATP-citrate
    lyase, ADP: Adenosine diphosphate, AK: Adenylate kinase, AKG: α-ketoglutarate,
    ALA: Extracellular alanine, AMP: Adenosine monophosphate, ARG: Extracellular arginine,
    ASN: Asparaginase, ASP: Extracellular aspartate, ATP: Adenosine triphosphate,
    CIT: Citrate, CO2: Carbone dioxide, DICLO: Extracellular diclofenac, EGLC: Extracellular
    glucose, EGLN: Extracellular glutamine, EGLU: Extracellular glutamate, F6P: Fructose-6-
    Phosphate, FADH2: Flavine adenine dinucleotide, FUM: fumarate, G6P: Glucose-6-phosphate,
    GAP: Glyceraldehyde 3-phosphate, concentration, GlnT: Glutamine synthetase, GLU:
    Glutamate, GLY: Extracellular Glycine, H2O: Hydrogen dioxide, HCIT: Extracellular
    hydroxicitrate, HIS: Extracellular histidine, HISARGTA: Histidine/arginine transamination,
    ILE: Extracellular isoleucine, LA: Extracellular lipoic acid, LAC: Extracellular
    lactate, LEU: Extracellular leucine, LYS: Extracellular lysine, MAL: Malate, ME:
    Malic enzyme, Metformin: Extracellular metformin, NAD: Nicotinamide adenine dinucleotide
    (Oxidized), NADH: Nicotinamide adenine dinucleotide (reduced), NADP: nictoniamide
    adenine dinucleottide phosphate, NADPH: nictoniamide adenine dinucleotide phosphate
    (reduced), NH4: Extracellular ammonia, OXA: Oxaloacetate, PALM: Palmitate, PEP:
    Phosphoenolpyruvate, Pi: inorganic phosphate, PK: Pyruvate kinase, PPRibP: Nucleotide
    synthesis, PYR: Pyruvate, R5P: Ribulose-5-phosphate, SER: Extracellular serine,
    SUC: succinate, SUCCOA: Succinyl coenzyme A, THR: Extracellular threonine, TYR:
    Extracellular tyrosine, VAL: Extracellular valine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - adp
  - G6P
  - rasp
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - pi
  - Pep
  - bgcn
  - pyr
  - Coa
  - mal
  - bs
  - Mrtf
  - Amph
  - sti
  - Suc
  - arg
  - aos
  - Kg
  - ATP8A2
  - WDTC1
  - DECR1
  - RASA1
  - RGS6
  - PALM
  - PAEP
  - PREP
  - PTPN22
  - MAL
  - MRTFA
  - TIRAP
  - APRT
  - MFAP1
  - CIT
  - DHDDS
  - HCA1
  - ABL2
  - RERE
  - ATP
  - ADP
  - Diclofenac
  - NADP
  - NADPH
  - NAD
  - amino acids
  - NADH
  - GLY
  - ALA
  - AMP
  - Metformin
  - HCA
  - VAL
  - TYR
  - ARG
---
